Prosthetic valve endocarditis

Journal of Cardiovascular Medicine

Volumn 11, Issue 12, 2010, Pages 869-883

  Nataloni, Maura ^a   Pergolini, Martina ^b   Rescigno, Giuseppe ^c   Mocchegiani, Roberto ^c  

^a Outpatient Cardiology Service   (Italy)

^b Jesi Hospital   (Italy)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

echocardiography; infective endocarditis; prosthetic heart valves

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B; AMPICILLIN; CASPOFUNGIN; CEFTRIAXONE; CEPHALOSPORIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; FLUCONAZOLE; GENTAMICIN; HEPARIN; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; MACROLIDE; OFLOXACIN; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; VANCOMYCIN; VORICONAZOLE;

ACUTE KIDNEY FAILURE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; BACTERIAL ENDOCARDITIS; BARTONELLOSIS; BLEEDING; BLOOD CULTURE; BRUCELLA; BRUCELLOSIS; CANDIDIASIS; CLINICAL FEATURE; COXIELLA BURNETII; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; EMBOLISM; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; FOLLOW UP; FUNGAL ENDOCARDITIS; HEART ARRHYTHMIA; HEART FAILURE; HEART PROTECTION; HEART VALVE PROSTHESIS; HEART VALVE REGURGITATION; HEART VALVE REPLACEMENT; HISTOPATHOLOGY; HUMAN; INCIDENCE; KIDNEY INFARCTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; MYCOSIS; NONHUMAN; PATHOGENESIS; PROGNOSIS; PROSTHETIC VALVE ENDOCARDITIS; Q FEVER; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS VIRIDANS INFECTION; THROMBOCYTOPENIA; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIOLOGICAL TECHNIQUES; DEVICE REMOVAL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; REOPERATION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 78649301357     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328336ec9a     Document Type: Review

References (109)

1. Habib G, Hoen B,Tornos P,Thuny F, Prendergast B, Vilacosta I, et al.The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology. Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and International Society of Chemotherapy (ISC) for Infection and Cancer. Guidelines on the Prevention, Diagnosis, and Treatment of Infective Endocarditis (newversion 2009). Eur Heart J 2009; 30:2493-2537.
2. Tugtekin S, Matschke K, Daubner D, Kappert U, Schueler S, Wilbring M, et al. Prosthetic valve endocarditis: importance of surgical treatment. Thorac Cardiovasc Surg 2007; 55:94-98.
3. Nunley DL, Perlman PE. Endocarditis: changing trends in epidemiology, clinical and microbiologic spectrum. Postgrad Med 1993; 93:235-247.
4. Barretta G, Sisani S, Marangoni G. Infective endocarditis: clinical echocardiography. Ital Heart J Suppl 2003; 4:935-956.
5. Sexton DJ, Spedman D. Current best practices and guidelines. Assessment and management of complications in infective endocarditis. Cardiol Clin 2003; 21:273-282.
6. Cecchi E, Imazio M, Trinchero R. The changing face of infective endocarditis. Heart2006; 92:1365-1366.
7. Heiro M, Helenius H, Makila S, Hohenthal U, Savunen T, Engblom E, et al. Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004. Heart 2006; 92:1457-1462.
8. Hasburn R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003; 289:1933-1940.
9. Karchmer AW. Infective endocarditis. In: Braunwald E, editor. Heart disease. A textbookofcardiovascularmedicine. Philadelphia, Pennsylvania, USA: WB Saunders; 2001. pp. 1723-1748.
10. Piper C, Korfer R, Horstkotte D. Valve disease. Prosthetic valve endocarditis. Heart 2001; 85:590-593.
11. Ivert TSA, Dismukes WE, Cobbs CG, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation 1984; 69:223-232.
12. Karchmer AW, Gibbons GW. Infections of prosthetic heart valves and vasculargrafts. In: Bisno AL,Waldvogel FA,editors. Infectionsassociated with indwelling medical devices. Washington, District of Columbia, USA: ASM Press; 1994. pp. 213-249.
13. Castillo JC, Anguita MP, Torres F, Mesa D, Franco M, Gonzalez E, et al. Long-term prognosis of early and late prosthetic valve endocarditis. Am J Cardiol 2004; 93:1185-1187.
14. Horskotte D, Piper C, Niehues R, Wiemer M, Schultheiss HP. Late prosthetic valve endocarditis. Eur Heart J 1995; 16 (Suppl B):39-47.
15. Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, et al., International Collaboration on Endocarditis Merged Database Study Group. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2005; 41:507-514.
16. Farinas MC, Perez-Vasquez A, Farinas-Alvarez C, Garcia-Palomo JD, Bernal JM, Revuelta JM, Gonzalez-Marcias J. Risk factors of prosthetic valve endocarditis: a case-control study. Ann Thorac Surg 2006; 81:1284-1290.
17. Moreillon P, Ai-Que Y. Infective endocarditis (seminar). Lancet 2004; 363:139-149.
18. Murray RJ. Staphylococcus aureus infective endocarditis: diagnosis and management guidelines. Intern Med J 2005; 35 (Suppl 2):S25-S44.
19. Cecchi E. Infective endocarditis: transesophageal echocardiography in all or in selected cases? When is echocardiography highly predictive for complications? Ital Heart J 2004; 5:656-662.
20. Enia F, Bella R, Mineo R, Mizio G, Reina G. An alarming problem in infective endocarditis therapy: antibiotic-resistance development. Ital Heart J Suppl 2005; 6:121-127.
21. Coleman DL, Horwitz RI, Andriole VT. Association between serum inhibitory and bactericidal concentrations and therapeutic outcome in bacterial endocarditis. Am J Med 1982; 73:260-267.
22. Millar BC, Moore JE. Current trends in the molecular diagnosis of infective endocarditis. Eur J Microb Infect Dis 2004; 23:353-365.
23. Bosshard PP, Kronenberg A, Zbinden R, Reuf C, Bottger EC, Altwegg M. Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3 year experience. Clin Infect Dis 2003; 37:167-172.
24. Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 2003; 82:322-332.
25. Ellis ME, Al-abdely H, Sandridge A, Greer W, Ventura V. Fungal endocarditis: evidencein the world literature, 1965-1995. Clin Infect Dis 2001; 32:50-62.
26. Horstkotte D, Weist K, Rueden H. Better understanding of the pathogenesis of prosthetic valve endocarditis: recent perspectives for prevention strategies. J Heart Valve Dis 1998; 7:313-315.
27. Gordon SM, Serkey JM, Longworth DL, Lytle BW, Cosgrove DM 3rd. Early onset prosthetic valve endocarditis: the Cleveland Clinic experience 1992-1997. Ann Thorac Surg 2000; 69:1388-1392.
28. Mocchegiani R, Pergolini M, Nataloni M. Infective endocarditis: outcome in surviving patients with intracardiac complications. J Cardiovasc Med 2007; 8:163-168.
29. Anguera I, Miro JM, Cabell CH, Abrutyn E, Fowler VG Jr, Hoen B, et al., and the ICE-MD investigators. Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the International Collaboration on Endocarditis Merged Database. Am J Cardiol 2005; 96:976-981.
30. Bortolotti U, Thiene G, Milano A, Panizzon G, Valente M, Gallucci V. Pathological study of infective endocarditis on Hancock porcine bioprostheses. J Thorac Cardiovasc Surg 1981; 81:934-942.
31. Pelletier LL Jr, Petersdorf RG, Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-72. Medicine (Baltimore) 1977; 56:287-313.
32. Von Reyn CF, Levy BS, Arberlt RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definition. Ann Intern Med 1981; 94:505-517.
33. Durak DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96:200-209.
34. Osler W. Malignant endocarditis. Lancet 1885; 1:415-418.
35. Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briancon S, et al., Association pour l'Etude et la Prévention de l'Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis. Result of a 1-year survey in France. JAMA 2002; 288:75-81.
36. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, et al., International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297:1354-1361.
37. Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Barwolf Ch, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart 2005; 91:571-575.
38. Beynon RP, Bahl VK, Prendergast BD. Infective endocarditis. BMJ 2006; 333:334-339.
39. Hill EE, Herijgers P, Herregods MC, Peetermans WE. Evolving trends in infective endocarditis. Clin Microbiol Infect 2006; 12:698-699.
40. Watkin RW, Lang S, Lambert PA, Littler WA, Elliott TS. The microbial diagnosis of infective endocarditis. J Infect 2003; 47:1-11.
41. Millar BC, Moore JE. Currenttrends in the moleculardiagnosisofinfective endocarditis. Eur J Clin Microbiol Infect Dis 2004; 23:353-365.
42. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-638.
43. Grijalva M, Horvath R, Dendis M, Erny J, Benedik J. Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients. Heart 2003; 89:263-268.
44. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davies JL, et al., American College of Cardiology; American Heart Association; American Society of Echocardiography. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article-a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the Guidelines for the Clinical Application of Echocardiography). Circulation 2003; 108:1146-1162.
45. Cecchi E, Trinchero R, Imazio M, Forno D, Dal Conte I, Lipani F, et al., and the Piedmont Infective Endocarditis Study Group. Are the Duke criteria really useful for the early bedside diagnosis of infective endocarditis? Results of a prospective multicenter trial. Ital Heart J 2005; 6:41-48.
46. Cosmi JE, Tunick PA, Kronzon I. Mortality in patients with paravalvular abscess diagnosed by transesophageal echocardiography. JAm Soc Echocardiogr2004; 17:766-768.
47. Tornos P. Management of prosthetic valve endocarditis: a clinical challenge. Heart2003; 89:245-246.
48. Agricola E, Oppizi M, Melisurgo G, Margonato A. Transesophageal echocardiography: a complementary view of the heart. Expert Rev Cardiovas Ther 2004; 2:61-75.
49. Sanfilippo AJ, Picard MH, Newell JB. Echocardiographic assessment of patientswith infectious endocarditis: prediction of riskforcomplication. JAm Coll Cardiol 1991; 18:1191-1199.
50. Di Salvo G, Habib G, Pergola V, Pergola V, Avierinos JF, Philip E, et al. Echocardiography predicts embolic events in infective endocarditis. JAm Coll Cardiol 2001; 37:1069-1076.
51. Di Salvo G, Pergola V, Pepi M, Marino P, Calabro' R, Habib G. on behalf of a Working Group of the Italian Society of Cardiology. Critical revision of the role of transesophageal echocardiography in the evaluation of the embolic riskofsubacute bacterial endocarditis. Ital Heart J Suppl 2004; 5:687-693.
52. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and transesophageal approach. JAm Coll Cardiol1989; 14:631-638.
53. Moon MR, Stinson EB, Miller DC Surgical treatment of endocarditis. Progr Cardiovasc Dis 1997; 40:239-264.
54. Barbour SI, Louie EK, O'Keefe JP. Penetration of the atrialventricular septum by spread of infection from aortic valve endocarditis: early diagnosis by transesophageal echocardiography and implications for surgical management. Am Heart J 1996; 132:1287-1289.
55. Daniel VG, Mugge A, Martin RP, Lindert O, Hausmann D, Nonnast-Daniel Barbara, et al. Improvementinthediagnosisofabscessesassociatedwith endocarditis by transesophageal echocardiography. N Engl J Med 1991; 324:795-800.
56. Shivley BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. JAm Coll Cardiol 1991; 18:391-397.
57. Lindner JR. Role of echocardiographic imaging in infective endocarditis. J Am Coll Cardiol 2002; 11:40-43.
58. Karalis DG, Bansal RC, Hauck AJ, Ross JJ Jr, Applegate PM, Jutzy KR, et al. Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis. Clinical and surgical implications. Circulation 1992; 86:353-362.
59. Reynolds HR, Jagen MA,Tunick PA, Kronzon I. Sensitivity oftransthoracic versus transesophageal echocardiography for the detection of native valve vegetations in the modern era. JAm Soc Echocardiogr2003; 16:67-70.
60. Shiller NB. Clinical decision making in endocarditis. In: Otto CM, editor. The practice of clinical echocardiography. Philadelphia, Pennsylvania, USA: WB Saunders; 2002. pp. 451-468.
61. Rozich JD, Edwards WD, Hanna RD, Laffey DM, Johnson GH, Klarich KW. Mechanical prosthetic valve associated strands: pathologic correlates to transesophageal echocardiography. JAm Soc Echocardiogr 2003; 16:97-100.
62. Choussat R, Thomas D, Isnard R, Michel PL, Lung B, Hanania G, et al. Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular Abscesses French Multicentre Study. Eur Heart J 1999; 20:232-241.
63. Greaves K, Mou D, Patel A, Celermajer DS. Clinical criteria and the appropriate use of transthoracic echocardiography for exclusion of infective endocarditis. Heart 2003; 89:1283-1284.
64. Douglas PS, Khandheria B, Stainback RF, Weissman NJ, Brindis RG, Patel MR, et al., American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group; American Society of Echocardiography; American College of Emergency Physicians; American Society of Nuclear Cardiology; Society for Cardiovascular Angiography and Interventions; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American College of Chest Physicians; Society of Critical Care Medicine. ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College ofChest Physicians and the Society of Critical Care Medicine. JAm Coll Cardiol 2007; 50:187-204.
65. Evangelista A, Gonzalez-Alujas MT. Echocardiography in infective endocarditis. Heart2004; 90:614-617.
66. Sochowski RA, Chan KL. Implications of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis. JAm Coll Cardiol 1993; 21:216-221.
67. Greaves K, Mou D, Patel A, Celermajer DS. Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart 2003; 89:273-278.
68. Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998; 98:2936-2948. (Pubitemid 29003982)
69. Kuyvenhoven P, Rijk-Zwikker GL, Hermans J, Thompson J, Huysmans HA. Prosthetic valve endocarditis: analysis of risk factors for mortality. Eur J Cardiothorac Surg 1994; 8:420-424.
70. Trunninger K, Attenhofer Jost CH, Seifert B,Vogt PR, Follath F, Schaffner A, Jenni R. Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone. Heart 1999; 82:714-720.
71. Yu VL, Fang GD, Keys TF, Harris AA, Gentry LO, Fuchs PC, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg 1994; 58:1073-1077.
72. Akowuah EF, Davies W, Oliver S, Stephens J, Riaz I, Zadik P, Cooper G. Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment. Heart 2003; 89:269-272.
73. Fedoruk LM, Jamieson WR, Ling H, MacNab JS, Germann E, Karim SS, et al. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis. J Thorac Cardiovasc Surg 2009; 137:326-333.
74. Calderwood SB, Swinski LA, Karkmer AW, Waternaux CM, Bukley MJ. Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg 1986; 92:776-783.
75. John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcusaureusprostheticvalveendocarditis:optimal management and riskfactors for death. Clin Infect Dis 1998; 26:1302-1309.
76. Mohan SS, McDermott BP, Cunha BA. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin. Heart Lung 2005; 34:69-71.
77. Cunha BA. Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. Clin Microbiol Infect 2005; 11 (Suppl 4):33-42.
78. Nalini R, White GJ. Successful treatment of Enterococcus faecalis prosthetic valve endocarditis with linezolid. Clin Infect Dis 2002; 35:902-904.
79. Stevens MP, Edmond MB. Endocarditis due to vancomycin-resistant enterococci:case reportand reviewof the literature. Clin Infect Dis 2005; 41:1134-1142.
80. Kupferwasser L, Yeaman R, Shapiro S, Nast CC, Sullam PM, Filler SG, et al. Acetylsalicylic acid reduces vegetation bacterial density, hematologenous bacterial dissemination and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999; 99:2791-2797.
81. Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med 1999; 159:473-475.
82. Anguera I, Del Rio A, Moreno A, Parè C, Mestres CA, Miro JM. Complications of native and prosthetic valve infective endocarditis: update in 2006. Curr Infect Dis Rep 2006; 8:280-288. (Pubitemid 44080966)
83. DiSalvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, et al. Echocardiography predicts embolic events in infective endocarditis. JAm Coll Cardiol 2001; 37:1069-1076.
84. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991; 114:635-640.
85. Espersen F, Frimodt-Moller N. Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med 1986; 146:1118-1121.
86. Di Nubile MJ. Heart block during bacterial endocarditis: a review of the literature and guidelines for surgical interventions. Am J Med Sci 1984; 287:30-32.
87. Nishimura RA, Carabello BA, Faxon DP, Freed MD, Lytle BW, O'Gara PT, et al.ACC/AHA2008 guideline updateonvalvularheartdisease:focused update on infective endocarditis-a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Endorsed by the Society of Cardiovascular Anesthesiologists, Societyfor Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52:676-685.
88. Cossart P, Jonquieres R. Sortase, auniversal targetfortherapeuticagents against gram-positive bacteria? Proc Natl Acad Sci USA 2000; 97:5013-5015.
89. Schaff HV, Carrel TP, Jamieson WR, Jones KW, Rufilanchas JJ, Cooley DA, et al. Paravalvular leak and other events in silzone-coated mechanical heartvalves: a reportfromAVERT. Ann Thorac Surg 2002; 73:785-792.
90. Renzulli A, Carozza A, Romano G, De Feo M, Della Corte A, Gregorio R, Cotrufo M. Recurrent infective endocarditis: a multivariate analysis of 21 years of experience. Ann Thorac Surg 2001; 72:39-43.
91. Jault F, Gandjbackhch I, Chastre JC, Levasseur JP, Bors V, Gibert C, et al. Prosthetic valve endocarditis with ring abscesses. Surgical management and long-term results. J Thorac Cardiovasc Surg 1993; 105:1106-1113.
92. Tornos MP, Olona M, Permanyer-Miralda G, Almirante B, Evangelista A, Soler-Soler J. Is the clinical spectrum and prognosis of native valve infective endocarditis in nonaddicts changing? Eur Heart J 1995; 16:1686-1691.
93. D'Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z. Long-term results of operation for paravalvular abscess. Ann Thorac Surg 1996; 62:48-53.
94. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society ofThoracic Surgeons. JAm Coll Cardiol 2006; 48:598-675.
95. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, et al., Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications-a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:394-434.
96. Lytle BW, Priest BP, Taylor PC, Loop FD, Sapp SK, Stewart RW, et al. Surgical treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1996; 111:198-207; discussion 207-210.
97. Avierinos JF, Thuny F, Chalvignac V, Giorgi R, Tafanelli L, Casalta JP, et al. Surgical treatment of active aortic infective endocarditis. Homografts are notthecornerstoneofoutcome. Ann Thorac Surg 2007; 84:1935-1942.
98. McGiffin DC, Kirklin JK. The impact of aortic valve homografts on the treatment of aortic prosthetic valve endocarditis. Semin Thorac Cardiovasc Surg 1995; 7:25-31.
99. Muller LC, Chevtchick O, Bonatti JO, Muller S, Fille M, Laufer G. Treatment of destructive aortic valve endocarditis with the freestyle aortic root bioprosthesis. Ann Thorac Surg 2003; 75:453-456.
100. Niwaya K, Knott-Craig CJ, Santangelo K, Lane MM, Chandrasekaran K, Elkins RC. Advantage of autograft and homograft valve replacement for complex aortic valve endocarditis. Ann Thorac Surg 1999; 67:1603-1608.
101. Takkenberg JJ, Dossche KM, Hazekamp MG, Nijveld A, Jansen EW, Waterbolk TW, Bogers AJ, Dutch Ross Study Group. Report of the Dutch experience with the Ross procedure in 343 patients. Eur J Cardiothorac Surg 2002; 22:70-77.
102. Guerra JM, Tornos MP, Permanyer-Miralda G, Almirante B, Murtra M, Soler-Soler J. Long term results of mechanical prostheses for treatment of active infective endocarditis. Heart 2001; 86:63-68.
103. Moon MR, Miller DC, Moore KA, Oyer PE, Mitchell RS, Robbins RC, et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg 2001;71:1164-1171.
104. Delay D, Pellerin M, Carrier M, Marchand R, Auger P, Perrault LP, et al. Immediate and long-term results of valve replacement for native and prosthetic valve endocarditis. Ann Thorac Surg 2000; 70:1219-1223.
105. Doty DB, Acar C. Mitral valve replacement with homograft Ann Thorac Surg 1998; 66:2127-2131.
106. David TE, Komeda M, Brofman PR. Surgical treatment of aortic root abscess. Circulation 1989; 80:1269-1274.
107. David TE, Feindel CM, Armstrong S, Sun Z. Reconstruction of the mitral annulus. A ten-year experience. J Thorac Cardiovasc Surg 1995; 110:1323-1332.
108. David TE, Kuo J, Armstrong S. Aortic and mitral valve replacement with reconstruction of the intervalvularfibrous body.J Thorac Cardiovasc Surg 1997; 114:766-771; discussion 771-772.
109. Ergin MA. Surgical techniques in prosthetic valve endocarditis. Semin Thorac Cardiovasc Surg 1995; 7:54-60.